Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 28051-28100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06788652
A Study of Patients With Relapsed/Refractory Mantle Cell Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
N/ARecruiting
300 participants
Started: Feb 4, 2025 · Completed: Sep 30, 2044
1 condition1 sponsor1 location
NCT06634368
Pilot Study of Hospital GamePlan4Care
NARecruiting
50 participants
Started: Feb 4, 2025 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT06794268
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
N/ARecruiting
300 participants
Started: Feb 4, 2025 · Completed: Aug 31, 2044
1 condition1 sponsor1 location
NCT06741475
Feasibility Study of Caregiver-Assist Strategy Training
NARecruiting
30 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor3 locations
NCT06795945
A Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Safety of a Bovine Thymus Nuclear Extract
NAActive, not recruiting
80 participants
Started: Feb 4, 2025 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT07017621
Qualitative Study on the Experiences of Mothers 6 to 12 Months After Their Participation in the Mother-baby Groups of the HUGS Study
N/ARecruiting
16 participants
Started: Feb 4, 2025 · Completed: Feb 4, 2026
2 conditions1 sponsor3 locations
NCT06852807
18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
N/ARecruiting
200 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06792175
Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models
N/AEnrolling by invitation
500 participants
Started: Feb 4, 2025 · Completed: Jul 31, 2026
8 conditions3 sponsors2 locations
NCT06801184
Single-center Exploratory Study of the Intestinal Microbiota in Patients Treated for Irritable Bowel Syndrome With Predominant Constipation and Methane Production
N/ANot yet recruiting
40 participants
Started: Feb 4, 2025 · Completed: Oct 4, 2026
1 condition1 sponsor1 location
NCT06758128
Genetic and Immunity in Heart Failure
N/ARecruiting
215 participants
Started: Feb 4, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor2 locations
NCT06300528
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
PHASE2Recruiting
27 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2030
1 condition2 sponsors1 location
NCT06800703
Opioid Use Disorder and Pain
N/ARecruiting
180 participants
Started: Feb 4, 2025 · Completed: Jan 31, 2028
2 conditions3 sponsors1 location
NCT06803784
Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders
N/ARecruiting
110 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2026
4 conditions2 sponsors1 location
NCT06829875
Are We Providing Timely Access to Musculoskeletal Outpatient Therapy Services? an Exploratory Study
N/ARecruiting
135 participants
Started: Feb 4, 2025 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05745285
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
NARecruiting
400 participants
Started: Feb 4, 2025 · Completed: Nov 1, 2026
5 conditions2 sponsors3 locations
NCT07001358
The Rufaida Project: Researching the Impact of Ramadan Fasting on the Gut and Vaginal Microbiome
N/AActive, not recruiting
350 participants
Started: Feb 4, 2025 · Completed: Feb 28, 2026
3 conditions1 sponsor1 location
NCT06550609
Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis with Inhaled Pentamidine Plus Oral Miltefosine
PHASE2Recruiting
30 participants
Started: Feb 4, 2025 · Completed: Feb 29, 2028
1 condition1 sponsor1 location
NCT06495593
Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis
PHASE4Recruiting
5 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06724380
Detection of Health Risk Situations in the Anesthesia Consultation.
N/ARecruiting
218 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06943547
The Effectiveness, Cost-effectiveness, and Budget Impact of Interventions to Improve the Delivery of Cervical Cancer Screening in Puerto Rico.
NAEnrolling by invitation
1,400 participants
Started: Feb 4, 2025 · Completed: Aug 31, 2028
1 condition2 sponsors1 location
NCT06743425
A Pilot Study of a Remote ADHD Monitoring Program
NARecruiting
36 participants
Started: Feb 4, 2025 · Completed: Jul 1, 2026
2 conditions4 sponsors2 locations
NCT07119437
Low Impact Laparoscopy In Bariatric Surgery
NARecruiting
128 participants
Started: Feb 4, 2025 · Completed: Oct 4, 2026
1 condition1 sponsor1 location
NCT06810245
Study of PIPE-791 for Subjects with Chronic Osteoarthritis Pain or Chronic Low Back Pain
PHASE1Recruiting
40 participants
Started: Feb 4, 2025 · Completed: Feb 15, 2026
2 conditions1 sponsor5 locations
NCT06808542
Pelvic Floor Dysfunction Among Female Physiotherapy Students: A Cross-Sectional Study
N/ARecruiting
180 participants
Started: Feb 4, 2025 · Completed: Apr 25, 2025
1 condition1 sponsor1 location
NCT07205588
Assessment of Dental Pathologies Using Digital Tools
N/ARecruiting
350 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2027
3 conditions1 sponsor22 locations
NCT06756932
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
PHASE1Recruiting
120 participants
Started: Feb 4, 2025 · Completed: Jul 30, 2027
3 conditions1 sponsor16 locations
NCT06794996
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or Without Comorbidities
PHASE2Recruiting
45 participants
Started: Feb 4, 2025 · Completed: Dec 30, 2026
1 condition1 sponsor34 locations
NCT06709014
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
PHASE3Recruiting
760 participants
Started: Feb 4, 2025 · Completed: Jun 30, 2028
1 condition2 sponsors84 locations
NCT06820918
Physiotherapy With Positive Expiratory Pressure (PEP) Bottle in Patients With Bronchiectasis
NAActive, not recruiting
30 participants
Started: Feb 4, 2025 · Completed: Jun 15, 2026
1 condition1 sponsor1 location
NCT06688968
Neuropsychological Profiles and Musical Engagement in Parkinson's and Alzheimer's Disease
NARecruiting
120 participants
Started: Feb 4, 2025 · Completed: Dec 1, 2025
3 conditions2 sponsors3 locations
NCT06247787
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
PHASE1Recruiting
36 participants
Started: Feb 4, 2025 · Completed: Jun 30, 2026
6 conditions3 sponsors17 locations
NCT06733480
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
NARecruiting
499 participants
Started: Feb 4, 2025 · Completed: Jun 1, 2026
3 conditions2 sponsors1 location
NCT06341205
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)
PHASE3Recruiting
120 participants
Started: Feb 4, 2025 · Completed: Sep 30, 2031
1 condition1 sponsor13 locations
NCT06791278
Improvements in Daily Activity and Exercise in School Children: the ActChild Study
NANot yet recruiting
600 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2032
9 conditions2 sponsors1 location
NCT06753474
A/Texas Flu Challenge
PHASE1Recruiting
50 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors2 locations
NCT06837454
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
N/ARecruiting
600 participants
Started: Feb 4, 2025 · Completed: Apr 9, 2027
1 condition1 sponsor1 location
NCT06704152
BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS
PHASE1/PHASE2Recruiting
38 participants
Started: Feb 4, 2025 · Completed: Mar 31, 2029
3 conditions1 sponsor6 locations
NCT06776952
A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
PHASE3Not yet recruiting
120 participants
Started: Feb 4, 2025 · Completed: Apr 30, 2028
1 condition1 sponsor0 locations
NCT06256393
Inflammatory Bowel Disease Cohort in Nantes
N/ARecruiting
360 participants
Started: Feb 4, 2025 · Completed: Feb 28, 2031
1 condition1 sponsor3 locations
NCT07105384
Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy
PHASE2Active, not recruiting
66 participants
Started: Feb 4, 2025 · Completed: Dec 20, 2028
1 condition1 sponsor1 location
NCT06877897
Comparing the Assessment Accuracy Between Submental Ultrasound and Speech Therapists in Nasogastric Tube Removal
NAEnrolling by invitation
150 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06431633
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
PHASE3Recruiting
129 participants
Started: Feb 4, 2025 · Completed: Nov 30, 2031
3 conditions1 sponsor30 locations
NCT06954597
Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
PHASE2Recruiting
15 participants
Started: Feb 4, 2025 · Completed: Mar 31, 2026
1 condition2 sponsors2 locations
NCT07008612
MYT1L Syndrome: a Rare Paediatric Genetic Syndrome Responsible for a Neurodevelopmental Disorder
N/ARecruiting
50 participants
Started: Feb 4, 2025 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT06618287
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
238 participants
Started: Feb 4, 2025 · Completed: Aug 24, 2028
2 conditions1 sponsor48 locations
NCT06588608
Auricular Vagus Nerve Stimulation (aVNS) in Chronic Spinal Cord Injuries (SCI)
NARecruiting
16 participants
Started: Feb 4, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06799936
A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians
NARecruiting
280 participants
Started: Feb 4, 2025 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT06629311
Platelet and Autotransfusion Device in Cardiac Surgery
N/ARecruiting
100 participants
Started: Feb 4, 2025 · Completed: Sep 8, 2026
2 conditions1 sponsor1 location
NCT06786091
Late Side-effects After Cervical Cancer Treatment - Prevention and Treatment
NAEnrolling by invitation
40 participants
Started: Feb 4, 2025 · Completed: Jul 31, 2026
7 conditions2 sponsors2 locations
NCT07085351
EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications
N/ARecruiting
70 participants
Started: Feb 4, 2025 · Completed: Sep 15, 2025
1 condition2 sponsors1 location